图:NIH historic image · Public domain · Wikimedia Commons
艾尔佛列·古曼·吉尔曼1941—2015
Alfred G. Gilman
生物学家, 美国
艾尔佛列·古曼·吉尔曼,美国药学家、生物化学家。因发现G蛋白与马丁·罗德贝尔一起分享1994年诺贝尔生理学或医学奖。
摘自维基百科「艾爾佛列·古曼·吉爾曼」,CC BY-SA 4.0
- 出生
- 1941 年 7 月 1 日,纽黑文
- 逝世
- 2015 年 12 月 23 日,达拉斯
- 国籍
- 美国
- 学科
- 化学、生物学、医学
- 职业
- 药理学家、药师、大学教师、生物化学家
- 母语 / 工作语言
- 英语
- 母校
- 耶鲁大学、弗吉尼亚大学、凯斯西储大学
- 工作单位
- 得克萨斯州大学达拉斯分校、弗吉尼亚大学
研究领域
所获奖项(7)
- 1975John J. Abel Award
- 1984盖尔德纳国际奖
- 1987理查德·劳恩斯伯里奖
- 1989拉斯克基础医学研究奖
- 1989路易莎·格罗斯·霍维茨奖
- 1994诺贝尔生理学或医学奖
- 1999honorary doctor of the University of Miami
学会与院士
百科正文
英文维基百科补充中文条目比较短,下面是英文条目「Alfred G. Gilman」的原文
Alfred Goodman Gilman (July 1, 1941 – December 23, 2015) was an American pharmacologist and biochemist. He and Martin Rodbell shared the 1994 Nobel Prize in Physiology or Medicine "for their discovery of G-proteins and the role of these proteins in signal transduction in cells."
Gilman was the son of Alfred Gilman, who co-authored Goodman & Gilman's The Pharmacological Basis of Therapeutics with Louis S. Goodman, from whom his middle name came. He earned a BA in biology with major in biochemistry from Yale University. Immediately after graduation in 1962, he worked with Allan Conney at Burroughs Wellcome & Company, which resulted in the publication of his first two technical papers. Persuaded by Earl Wilbur Sutherland, Jr., he joined Case Western Reserve University School of Medicine for an MD–PhD course. He obtained his degree in 1969. He then went to the National Institutes of Health to work with Marshall Nirenberg between 1969 and 1971.
Gilman became assistant professor of pharmacology at the University of Virginia School of Medicine in 1971, and full professor in 1977. He chaired the Department of Pharmacology at the University of Texas Southwestern Medical Center at Dallas from 1981. Upon his retirement in 2009, he was appointed chief scientific officer of the Cancer Prevention and Research Institute of Texas. He resigned in 2012. He was the founder of Regeneron Pharmaceuticals company and the Alliance for Cellular Signaling. From 2005, he was also director of Eli Lilly and Company.
G proteins are a vital intermediary between the extracellular activation of receptors (G protein-coupled receptors) on the cell membrane and actions within the cell. Rodbell had shown in the 1960s that GTP was involved in cell signaling. It was Gilman who actually discovered the proteins that interacted with the GTP to initiate signalling cascades within the cell, and thus, giving the name G proteins.
For his works, he received the Canada Gairdner Foundation International Award in 1984, Albert Lasker Award for Basic Medical Research and the Louisa Gross Horwitz Prize in 1989, in addition to Nobel Prize. He was elected member of the National Academy of Sciences and American Academy of Arts and Sciences, Fellow of the American Association for Cancer Research Academy, and, since 2013 (or earlier), member of the advisory council of the National Center for Science Education.
Death
Gilman died after a long battle with pancreatic cancer in Dallas, Texas, on December 23, 2015, at the age of 74. He was survived by his wife and three children, Amy Ariagno and Anne Sincovec, both of Dallas, and Edward Gilman of Austin.
以上节选摘自英文维基百科「Alfred G. Gilman」,按 CC BY-SA 4.0 使用,去掉了参考文献、外部链接等尾部小节,公式改写成了纯文本。篇幅所限,较长的小节只摘了开头一部分,有的小节没有收;全文、配图和出处见原文。
同年获同一奖项
同一学科、同时代的科学家
同一学科的科学家
更多 ›



